random effects. Results displayed in columns (B) and (C) of table 2 reinforce the
absence of influence of fair valuation in volatility of profits. Both models present a
significant goodness-of-fit and the expected significant positive sign for the control
variables. In none of the columns the dummy variable for valuation method presents a
significant sign.
Therefore, estimations from table 2 reinforce our finding that fair valuation of biological
assets is not associated with higher volatility.